S&P 500 Jumps 2.2% on Job Data 📈

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Happy Friday! It's January 6th. I hope you have a great weekend! Before we get started, I just want to remind you that you can get free closing bell alerts on your mobile device by texting CLOSE to 47121 or [clicking here](. Sign up now to start the New Year off right and stay up-to-speed on the hottest stocks! Here's what moved the market today: Markets 📈 US benchmarks rallied today in response to the December jobs report. The S&P 500 [+2.2%], Nasdaq [+2.5%], Dow [+2.1%] and small-cap Russell 2K [-2.2%] all gained more than 2.0%. Sponsored [The Top 5 NASDAQ Stocks to Own for New Year 2023 📈]( Even in the worst of times, markets have rallied back. Just as they always have. So, if you're thinking of quitting the market, don't. There are plenty of bargains and hot stocks to jump on. In fact, we believe these five stocks look like they could see big gains in 2023. [Click Here to Get the FREE Report]( Today's Market-Moving News 🔎 💼 December Job Data: The US economy added 223,000 non-farm payrolls in December, surpassing the estimate of 200,000, but it was a slowdown from November's 256,000 figure. 🛠Unemployment Falls: The unemployment rate fell to 3.5% in December from 3.6% in the previous month. Today's Top Winners and Losers 🔥 Fate Therapeutics [FATE] $4.24 (-61.4%) Fate Therapeutics announced the termination of a collaboration and option agreement with Johnson & Johnson's [JNJ +0.8%] Janssen Biotech unit. The company also said it's slashing its staff and discontinuing some of its natural killer cell programs. Nabriva Therapeutics [NBRV] $1.30 (-44.8%) Nabriva Therapeutics' board approved a plan to wind down operations and terminate all non-essential employees at the company. Graphite Bio [GRPH ://elitetra.de/L2Ic ] $1.85 (-39.5%) Graphite Bio voluntarily paused a Phase 1/2 CEDAR study of nulabeglogen autogedtemcel for sickle cell disease due to a serious adverse event. Spruce Biosciences [SPRB] $2.42 (+93.6%) Spruce Bio signed an exclusive licensing deal with Kaken Pharmaceuticals for developing tildacerfont in Japan. The tiny biotech firm will get a $15 million upfront payment, plus additional milestone payments and tiered royalties under the terms of the agreement. MultiMetaVerse [MMV] - Last Close: $11.63 (+82.0%) MultiMetaVerse soared in its second day of trading since completing its business combination with Model Performance Acquisition SPAC, which previously traded under the symbol MPAC. UPDATE: This stock is falling fast in the after-hours. CytomX Therapeutics [CTMX] $2.52 (+40.7%%) CytomX Therapeutics announced a deal with Moderna [MRNA +3.9%] to develop investigational mRNA-based therapies early this morning. The company will get $35 million upfront, plus up to $1.2 billion in potential milestone payments and tiered royalties on any products developed under the collaboration. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](